Chien-Ching Li

Dr. Chien-Ching Li


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2015 in LGBT Health
Verified
Journal Article
Closed access
CLChien-Ching Li
Chien-Ching Li
AMAlicia K. Matthews
Alicia K. Matthews
FAFrances Aranda
Frances Aranda
CPChirag Patel
Chirag Patel
MPMaharshi Patel
Maharshi Patel
Purpose: Using Andersen's Behavioral Model of Health Services Utilization, we examined the associations between negative experience in a health care setting and subsequent reductions in health care utilization among African American sexual minority women (SMW). Methods: The data were collected as part of a larger study exploring health and health care experiences of a volunteer sample of African American SMW ( n =226). We examined predisposing, enabling, and need factors as predictors of a negative experience and changes in health care utilization. Results: More than one-third of the sample reported a negative health care experience in the past 5-years. One fourth of those reporting a negative experience attributed it to discrimination including race/ethnicity (70.4%), gender (58.2%), and sexual orientation (46.2%). (The categories were not mutually exclusive). Reduction in health care utilization (i.e., didn't see a doctor next time when they were ill) following the negative experience was common (34%). Predisposing (younger age), enabling (lack of insurance, part-time employment, and no regular provider), and need factors (living with a chronic illness) predicted experiencing a negative event. In multivariate analysis, health care factors (quality of health care, negative experience due to discrimination) and patient factors (passive coping response) were factors associated with reduced health care utilization. Conclusion: Problems in the patient-provider relationship were a significant factor in decreasing healthcare use among SMW. Anderson's model helped to inform our understanding of who might be at risk of experiencing a negative experience but not subsequent changes in health care utilization. Modifiable variables related to the health care environment and patient coping responses predicted changes in health care use.

1 January 2013 in Journal of Environmental and Public Health
Verified
Journal Article
Open access
PDF file
AMAlicia K. Matthews
Alicia K. Matthews
CLChien-Ching Li
Chien-Ching Li
LKLisa M. Kuhns
Lisa M. Kuhns
TTTimothy B. Tasker
Timothy B. Tasker
JCJohn A. Cesario
John A. Cesario
Introduction. Little is known about lesbian, gay, bisexual, and transgender (LGBT) people’s response to smoking cessation interventions. This descriptive study examined the benefits of a community-based, culturally tailored smoking cessation treatment program for LGBT smokers.Methods. A total ofN=198LGBT individuals recruited from clinical practice and community outreach participated in group-based treatment. Sessions were based on the American Lung Association’s “Freedom from Smoking Program” (ALA-FFS) and were tailored to LGBT smokers’ needs. Seven-day smoking point prevalence abstinence served as the primary outcome.Results. Participants (Mage = 40.5) were mostly White (70.4%) and male (60.5%) and had at least a college degree (58.4%). Forty-four percent scored in the moderate range on the Fagerström Test for Nicotine Dependence pretreatment, and 42.4% completed treatment (≥75% sessions). Higher educational attainment and use of nicotine replacement therapy (NRT) were associated with treatment completion. Self-reported quit rates were 32.3% at posttreatment assessment. Treatment attendance (OR = 2.45), use of NRT (OR = 4.24), and lower nicotine dependency (OR = 0.73) were positively associated with quitting smoking.Conclusions. Results suggest the benefits of offering LGBT smokers culturally tailored smoking cessation treatments. Future research could improve outcomes by encouraging treatment attendance and promoting NRT uptake.

26 May 2017 in Journal of Health Communication
Verified
Journal Article
Closed access
CLChien-Ching Li
Chien-Ching Li
AMAlicia K. Matthews
Alicia K. Matthews
MDMazahir Dossaji
Mazahir Dossaji
FFFrancis Fullam
Francis Fullam
Prior research has demonstrated poorer patient–provider communication ratings among African American compared to White patients. The quality of patient–provider communication has been shown to impact treatment outcomes among cancer patients. A secondary data analysis design was used to determine the relationship of six patient–provider communication variables on the physical health quality of life (PHQOL) and mental health quality of life (MHQOL) of African American and White cancer patients (N = 479). We also examined whether the relationship between communication patterns and QOL differed based on race/ethnicity. Mean physical and mental health QOL scores for the sample were 69.8 and 77.6, respectively. After controlling for significant sociodemographic, clinical, and hospital variables, results showed that patients who experienced fewer interpersonal communication barriers who were more satisfied with the information given by providers had higher PHQOL and MHQOL scores. Additionally, patients who felt more comfort in asking questions or had fewer unmet information needs had higher MHQOL. A stratified analysis showed that the relationship of overall satisfaction with information on MHQOL was stronger among African American patients than White patients. Future research should focus on the development of interventions to improve patient–provider communication as a means for enhancing QOL outcomes among cancer survivors.

31 August 2018 in Nicotine & Tobacco Research
Verified
Journal Article
Closed access
PDF file
AMAlicia K Matthews
Alicia K Matthews
ASAlana D Steffen
Alana D Steffen
LKLisa M Kuhns
Lisa M Kuhns
RRRaymond A Ruiz
Raymond A Ruiz
NRNat A Ross
Nat A Ross
AKAndrea C King
Andrea C King
To examine the benefits of a culturally targeted compared with a nontargeted smoking cessation intervention on smoking cessation outcomes among lesbian, gay, bisexual, and transgender (LGBT) smokers. A prospective randomized design was used to evaluate the added benefits of an LGBT culturally targeted Courage to Quit (CTQ-CT) smoking cessation treatment (N = 172) compared with the standard intervention (CTQ; N = 173). The smoking cessation program consisted of six treatment sessions combined with 8 weeks of nicotine replacement therapy. The primary smoking cessation outcome was 7-day point prevalence quit rates. Secondary outcomes examined included changes in nicotine dependence, nicotine withdrawal, cigarettes per day, smoking urges, self-efficacy, and readiness to quit. Overall quit rates were 31.9% at 1 month, 21.1% at 3 months, 25.8% at 6 months, and 22.3% at 12 months. Quit rates did not differ between treatment groups [1 month OR = 0.81 (0.32, 2.09), 3 months OR = 0.65 (0.23, 1.78), 6 months OR = 0.45 (0.17, 1.21), 12 months OR = 0.70 (0.26, 1.91)]. Compared with baseline levels, all secondary smoking cessation outcomes measured were improved at 1 month and were maintained at 12-month follow-up. Compared with the CTQ, the CTQ-CT intervention was more highly rated on program effectiveness (d = 0.2, p = .011), intervention techniques (d = 0.2, p = .014), the treatment manual (d = 0.3, p < .001), and being targeted to the needs of LGBT smokers (d = 0.5, p < .0001). LGBT smokers receiving the CTQ intervention achieved smoking cessation outcomes in the range reported for other demographic groups. Cultural targeting improved the acceptability of the intervention but did not confer any additional benefit for smoking cessation outcomes. Study results have implications for understanding the benefits of culturally targeted compared with nontargeted smoking cessation interventions for improving smoking cessation outcomes among LGBT smokers. Shorter and longer term 7-day point prevalence quit rates associated with the targeted and nontargeted interventions were modest but comparable with other group-based interventions delivered in a community setting. Although cultural targeting improved the overall acceptability of the intervention, no added benefits were observed for the culturally targeted intervention on either the primary or secondary outcomes.

3 May 2011 in Neurology
Verified
Journal Article
Closed access
PDF file
AAA. Alshekhlee
A. Alshekhlee
CLChien-Ching Li
Chien-Ching Li
SCS.-Y. Chuang
S.-Y. Chuang
NVN. Vora
N. Vora
RER.C. Edgell
R.C. Edgell
SCS. Cruz-Flores
S. Cruz-Flores
Background: Dementia represents a potential challenge when thrombolysis is a treatment option. In this study, we assess the impact of dementia on the rate of intracerebral hemorrhage (ICH) and hospital mortality associated with acute ischemic stroke (AIS) in patients treated with thrombolysis. Methods: A cohort of patients with AIS was identified from the National Inpatient Sample database for the years 2000 to 2007. Vascular and degenerative types of dementia were identified by the International Classification of Diseases–9-CM codes. A matched random sample without dementia was selected from a pool of those with AIS and treated with thrombolysis. Results: In this analysis, 35,557 patients with diagnosis of dementia were included; 207 (0.56%) received thrombolysis. In-hospital mortality (17.48% vs 8.63%) and ICH (5.80% vs 0.38%) were higher in the thrombolysis group (p < 0.0001) compared to those who did not receive thrombolysis. Multivariate analysis showed that thrombolysis was associated with increased hospital mortality (odds ratio [OR] 16.15; 95% confidence interval [CI] 8.54–30.53) and ICH (OR 2.80; 95% CI 1.82–4.32). Compared to a matched population of patients without dementia treated with thrombolysis (n = 621), those who had dementia and were treated with thrombolysis had similar risks of ICH (5.80% vs 4.51%, p = 0.45) and mortality (17.39% vs 14.49%, p = 0.31) rates. With thrombolysis, ICH remained a predictor of mortality for both dementia and control groups (OR 2.25; 95% CI 1.02–4.99). Conclusion: The administration of thrombolysis for AIS in patients with dementia was not associated with increased risk of ICH or death compared to the counterparts without dementia. ICH remained as predictor of mortality.

30 October 2018 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
CLChien-Ching Li
Chien-Ching Li
AMAlicia K. Matthews
Alicia K. Matthews
MRMantle M. Rywant
Mantle M. Rywant
EHEmily Hallgren
Emily Hallgren
RSRaj C. Shah
Raj C. Shah